Posts
May 03 2017
On April 26, 2017, the Appellate Division, Second Department issued a decision reversing the Surrogate of Rockland County who had previously granted petitioner’s motion for summary judgment against EGS client, Alfred Zucaro. In reversing, the Second Department also granted Mr. Zucaro summary judgment dismissing petitioner’s conversion cause of action against him.
James K. Landau, a member of the Firm, represented Mr. Zucaro in connection with the appeal. A copy of the decision can be found at http://law.justia.com/cases/new-york/appellate-division-second-department/2017/2015-02684.html.
May 01 2017
The Deal issued its quarterly PIPE league tables, revealing that 2017’s first quarter outperformed last year’s first quarter. Deals were up nearly 75% from the previous year to 367, while dollars raised were up almost 70% to $21.3 billion.
EG&S is top ranked. Click here to read the article.
May 01 2017
CytRx Corporation announced the closing of their Registered Direct in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
April 28 2017
BioPharm X Corporation announced the closing of their Registered Direct offering in the amount of $5,000,001. EG&S acted as counsel to the lead Investor.
April 27 2017
Aeterna Zentaris Inc. announced the implementation of their At the Market offering in the amount of $6,944,000. EG&S acted as counsel to the Placement Agent.
April 26 2017
Apricus Biosciences, Inc. announced the closing of their Underwritten offering in the amount of $7,042,000. EG&S acted as counsel to the Underwriter.
April 24 2017
Sunshine Heart, Inc. announced the closing of their Underwritten offering in the amount of $8,372,000. EG&S acted as counsel to the Underwriter.
April 21 2017
Social Reality Inc. announced the closing of their PIPE offering in the amount of $5,000,000. EG&S acted as counsel to the lead Investor.